Promising Dividend Stocks To Watch Now – March 21st

ProShares UltraPro Short QQQ, Direxion Daily TSLA Bull 2X Shares, BP, Chevron, Exxon Mobil, AbbVie, and Johnson & Johnson are the seven Dividend stocks to watch today, according to MarketBeat’s stock screener tool. Dividend stocks are shares of companies that distribute a portion of their earnings to shareholders in the form of dividends. These stocks are popular among investors seeking regular income in addition to potential capital gains, and they tend to come from well-established companies with stable cash flows. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

Shares of NASDAQ SQQQ traded up $0.36 during midday trading on Friday, reaching $37.11. 56,186,239 shares of the stock were exchanged, compared to its average volume of 39,686,136. The stock has a 50 day moving average price of $31.03 and a 200-day moving average price of $33.54. ProShares UltraPro Short QQQ has a 52-week low of $26.21 and a 52-week high of $64.95.

Direxion Daily TSLA Bull 2X Shares (TSLL)

TSLL stock traded up $0.62 during midday trading on Friday, hitting $8.78. The stock had a trading volume of 150,817,490 shares, compared to its average volume of 62,595,650. The company’s 50-day moving average price is $19.06 and its 200 day moving average price is $18.77. The firm has a market cap of $1.70 billion, a PE ratio of 43.99 and a beta of -5.14. Direxion Daily TSLA Bull 2X Shares has a 12-month low of $4.94 and a 12-month high of $41.50.

BP (BP)

BP p.l.c. provides carbon products and services. The company operates through Gas & Low Carbon Energy, Oil Production & Operations, and Customers & Products segments. It engages in the production of natural gas, and integrated gas and power; trading of gas; operation of onshore and offshore wind power, as well as hydrogen and carbon capture and storage facilities; trading and marketing of renewable and non-renewable power; and production of crude oil.

BP stock traded down $0.14 during trading on Friday, hitting $34.62. The company’s stock had a trading volume of 38,025,921 shares, compared to its average volume of 9,157,053. The stock’s fifty day moving average is $32.63 and its 200 day moving average is $31.27. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.97 and a current ratio of 1.25. BP has a 1-year low of $27.82 and a 1-year high of $40.40. The stock has a market capitalization of $92.67 billion, a price-to-earnings ratio of 432.59, a P/E/G ratio of 1.12 and a beta of 0.58.

Chevron (CVX)

Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant.

Shares of NYSE CVX traded down $0.97 on Friday, reaching $163.80. 7,041,680 shares of the company traded hands, compared to its average volume of 7,282,853. The company has a 50 day moving average of $156.07 and a 200 day moving average of $152.40. The company has a current ratio of 1.07, a quick ratio of 0.80 and a debt-to-equity ratio of 0.13. Chevron has a fifty-two week low of $135.37 and a fifty-two week high of $167.11. The stock has a market capitalization of $288.39 billion, a PE ratio of 16.85, a P/E/G ratio of 1.46 and a beta of 1.08.

Exxon Mobil (XOM)

Exxon Mobil Corporation engages in the exploration and production of crude oil and natural gas in the United States and internationally. It operates through Upstream, Energy Products, Chemical Products, and Specialty Products segments. The Upstream segment explores for and produces crude oil and natural gas.

XOM stock traded down $0.88 on Friday, hitting $115.02. 9,980,658 shares of the company were exchanged, compared to its average volume of 14,856,318. Exxon Mobil has a twelve month low of $103.67 and a twelve month high of $126.34. The business’s fifty day moving average is $109.92 and its two-hundred day moving average is $113.60. The stock has a market capitalization of $499.10 billion, a price-to-earnings ratio of 14.68, a price-to-earnings-growth ratio of 3.02 and a beta of 0.83. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.31 and a quick ratio of 0.97.

AbbVie (ABBV)

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

Shares of NYSE ABBV traded down $2.66 during midday trading on Friday, hitting $209.30. The stock had a trading volume of 4,743,770 shares, compared to its average volume of 5,200,403. AbbVie has a 1-year low of $153.58 and a 1-year high of $218.66. The company has a fifty day moving average price of $193.80 and a 200 day moving average price of $188.64. The company has a quick ratio of 0.55, a current ratio of 0.66 and a debt-to-equity ratio of 17.94. The company has a market capitalization of $369.49 billion, a price-to-earnings ratio of 87.21, a PEG ratio of 1.62 and a beta of 0.61.

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

JNJ traded up $0.04 during trading on Friday, hitting $163.06. 5,459,248 shares of the company’s stock were exchanged, compared to its average volume of 7,044,174. The stock has a 50 day moving average price of $156.57 and a 200 day moving average price of $156.34. Johnson & Johnson has a 1 year low of $140.68 and a 1 year high of $169.99. The company has a current ratio of 1.11, a quick ratio of 0.86 and a debt-to-equity ratio of 0.43. The firm has a market cap of $392.94 billion, a P/E ratio of 24.52, a price-to-earnings-growth ratio of 2.56 and a beta of 0.47.